Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 5133 · Patients’ Right to Know Their Medication Act of 2025 ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

21 U.S.C. § 352 Misbranded drugs and devices

+2 −0Shown
More for 21 U.S.C. § 352
Read § 352Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) is amended by adding at the end the following:(hh) If it is a drug subject to section 503(b)(1) and patient medication information is not provided in accordance with section 505H..

§ 352(gg)–(hh)

Start of § 352 to (gg)(2)(E) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(gg)(2)(F)(F) (F)
product-related programs or services; andproduct-related programs or services; and
(gg)(2)(G)(G) (G)
factual presentations of results from studies that do not characterize or make conclusions regarding safety or efficacy.factual presentations of results from studies that do not characterize or make conclusions regarding safety or efficacy.
(hh)(hh) [inserted: ]
[inserted: If it is a drug subject to section 503(b)(1) and patient medication information is not provided in accordance with section 505H.]

Step through the changes